MedTrace Logo

Smoking Cessation Pilot for People Living With HIV (PLWH)

NCT04808609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-02-23

Study results available
· View outcomes & findings →

Summary

The overall goal of this pilot study is to evaluate the feasibility of the Lumme smartphone app for smoking cessation in people living with HIV (PLWH) and evaluate its effect on smoking cessation. Mobile health (mHealth) technology can be used for achieving health equity in vulnerable groups because it is a widely available and relatively inexpensive tool for health behavior change and can be adapted to meet the needs of its end-users. Therefore, a mHealth intervention such as the Lumme App proposed through this study is timely, relevant, scalable and likely to improve health outcomes in PLWH who smoke.

Conditions

  • Smoking Cessation
  • Smoking
  • Smoking Behaviors
  • Smoking Reduction
  • Smoking, Tobacco
  • Smoking, Cigarette
  • Hiv
  • HIV/AIDS

Interventions

DEVICE

Lumme mobile phone application

Lumme mobile phone app provides smoking cessation support and tracks smoking behaviors

BEHAVIORAL

Standard of Care

Smoking cessation counseling and nicotine replacement therapy

Sponsors & Collaborators

Principal Investigators

  • Rebecca Schnall, PhD, RN · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2021-07-16
Completion
2021-07-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04808609 on ClinicalTrials.gov